Talicia J. Savage

Oncology

1950 Circle Of Hope Dr
Salt Lake City, UT 84112

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer.

Durable response to BRAF inhibitor monotherapy in recurrent metastatic low grade serous ovarian cancer.

Journal: Gynecologic oncology reports

Published: March 18, 2024

Association Between Patient-Level, Clinic-Level, and Geographical-Level Factors and 1-Year Surveillance Colonoscopy Adherence.

Association Between Patient-Level, Clinic-Level, and Geographical-Level Factors and 1-Year Surveillance Colonoscopy Adherence.

Journal: Clinical and translational gastroenterology

Published: November 28, 2022

Postablation Modulation after Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation.

Postablation Modulation after Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 26, 2018

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy.

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy.

Journal: Oncotarget

Published: July 16, 2016

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy.

Journal: PloS one

Published: March 10, 2016

TGFβ inhibition prior to hypofractionated radiation enhances efficacy in preclinical models.

TGFβ inhibition prior to hypofractionated radiation enhances efficacy in preclinical models.

Journal: Cancer immunology research

Published: July 23, 2014

Expression of arginase I in myeloid cells limits control of residual disease after radiation therapy of tumors in mice.

Expression of arginase I in myeloid cells limits control of residual disease after radiation therapy of tumors in mice.

Journal: Radiation research

Published: July 04, 2014

The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.

The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.

Journal: PloS one

Published: April 05, 2013

Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approach.

Circulating and intratumoral macrophages in patients with hepatocellular carcinoma: correlation with therapeutic approach.

Journal: American journal of surgery

Published: November 01, 2012

Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.

Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.

Journal: PloS one

Published: February 29, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026